Applied Spectral Imaging

Automated Imaging Platforms for Pathological Analysis

Health Tech & Life Sciences
Acquired by ZYTOMICS on Aug 2025
Acquired Yokne'am Illit Founded 1993
Total raised
$11.0M
Last: Undisclosed 2020-08
Stage
Acquired
Founded
1993
Headcount
83
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences

About

Applied Spectral Imaging (ASI) develops biomedical microscopy imaging. The Company’s advanced technology provides Pathology, Cytogenetics and Research laboratories with end-to-end solutions from slide scanning, high-resolution Whole Slide Imaging (WSI), quantitative analysis, reporting, and all the way to LIS connectivity.

ASI’s products are powered by GenASIs, its core technology and the backbone of its systems. Combining image acquisition with computer-assisted analysis, its systems enable laboratories to provide advanced diagnostics to patients, grounded on powerful algorithms and customer focused software. Its wide portfolio of dedicated solutions for Brightfield, Fluorescence and Spectral imaging and analysis includes HiPath Pro, PathFusion, HiBand, HiFISH, CytoPower and Rainbow.

Funding history · 2 rounds · $11.0M total

2020-08
Undisclosed $11.0M
1998-01
Undisclosed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Platforms & InterfacesSoftwareSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesBiotechnology
Business model
B2B

Highlights

1 Patents

Tags

diagnosticslaboratoriesimagingdetectionhospitalsgeneticscancermedical-image-analysismedical-technologiesoptronics